+62.2%
GSK vs DOC
+20.8%
+41.5%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | DOC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.8% | -0.1% | -1.6% |
| 7D | -1.8% | -1.5% | -0.4% | -1.6% |
| 30D | -2.2% | -4.8% | +2.6% | -1.3% |
| 3M | -1.8% | +6.9% | -8.7% | -2.9% |
| 6M | -10.6% | +20.7% | -31.4% | -13.5% |
| YTD | +4.4% | +34.1% | -29.7% | -1.1% |
| 1Y | +30.4% | +22.6% | +7.8% | +25.3% |
| All | +62.2% | +20.8% | +41.5% | +66.5% |
Cumulative growth
Daily Returns
Daily percentage return beside DOC.
Daily Out/Under-Performance
Portfolio return minus DOC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DOC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded DOC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling